Alterations of SAG mRNA in human cancer cell lines: Requirement for the RING finger domain for apoptosis protection

Carcinogenesis

Volumn 20, Issue 10, 1999, Pages 1899-1903

  Sun, Yi ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METAL ION; ZINC FINGER PROTEIN;

AMINO ACID SEQUENCE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL PROTECTION; COLON CARCINOMA; CONTROLLED STUDY; DELETION MUTANT; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS CARCINOMA;

EID: 0032877005     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.10.1899     Document Type: Article

References (36)

1. Weinberg, R.A. (1985) The action of oncogenes in the cytoplasm and nucleus. Science, 230, 770-776.
2. Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
3. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
4. Chipperfield, R.G., Jones, S.S., Lo, K.M. and Weinberg, R.A. (1985) Activation of Ha-ras p21 by substitution, deletion and insertion mutations. Mol. Cell. Biol., 5, 1809-1813.
5. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
6. Cunningham, J.M. and Weinberg, R.A. (1985) Ras Oncogenes in Human Tumours: Identification, Mechanism of Activation and Cooperative Role in Transformation. IARC Scientific Publications no. 60, IARC, Lyon, pp. 359-364.
7. Deng, H.X., Hentati, A., Tainer, J.A. et al. (1993) Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase [see comments]. Science, 261, 1047-1051.
8. Rosen, D.R., Siddique, T., Patterson, D. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis [see comments]. Nature, 362, 59-62. [Erratum (1993) Nature, 364, 362.]
9. Thompson, C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
10. Wyllie, A.H., Kerr, J.F. and Currie, A.R. (1980) Cell death: the significance of apoptosis. Int Rev. Cytol., 68, 251-306.
11. Baker, A., Payne, C.M., Briehl, M.M. and Powis, G. (1997) Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res., 57, 5162-5167.
12. Kayanoki, Y., Fujii, J., Islam, K.N., Suzuki, K., Kawata, S., Matsuzawa, Y. and Taniguchi, N. (1996) The protective role of glutathione peroxidase in apoptosis induced by reactive oxygen species. J. Biochem. Tokyo, 119, 817-822.
13. Kondo, Y., Rusnak, J.M., Hoyt, D.G., Settineri, C.E., Pitt, B.R. and Lazo, J.S. (1997) Enhanced apoptosis in metallothionein null cells. Mol. Pharmacol., 52, 195-201.
14. Manna, S.K., Zhang, H.J., Yan, T., Oberley, L.W. and Aggarwal, B.B. (1998) Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J. Biol. Chem., 273, 13245-13254.
15. Duan, H., Wang, Y., Aviram, M., Swaroop, M., Loo, J.A., Bian, J., Tian, Y., Mueller, T., Bisgaier, C.L. and Sun, Y. (1999) SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents. Mol. Cell. Biol., 19, 3145-3155.
16. Sun, Y., Hegamyer, G., Cheng, Y.J., Hildesheim, A., Chen, J.Y., Chen, I.H., Cao, Y., Yao, K.T. and Colburn, N.H. (1992) An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad. Sci. USA, 89, 6516-6520.
17. Sun, Y., Nakamura, K., Hegamyer, G., Dong, Z. and Colburn, N. (1993) No point mutation of Ha-ras or p53 genes expressed in preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Mol. Carcinog., 8, 49-57.
18. Sun, Y., Hildesheim, A., Li, H. et al. (1995) No point mutation but a codon 31ser→arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiol Biomarkers Prev., 4, 261-267.
19. Sun, Y., Pommier, Y. and Colburn, N.H. (1992) Acquisition of a growth-inhibitory response to phorbol ester involves DNA damage. Cancer Res., 52, 1907-1915.
20. Sun, Y., Bian, J., Wang, Y. and Jacobs, C. (1997) Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound. Oncogene, 14, 385-393.
21. Bass, B.L. (1997) RNA editing and hypermutation by adenosine deamination. Trends Biochem. Sci., 22, 157-162. [Erratum (1997) Trends Biochem. Sci., 22, 278.]
22. Burns, C.M., Chu, H., Rueter, S.M., Hutchinson, L.K., Canton, H., Sanders Bush, E. and Emeson, R.B. (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing [see comments]. Nature, 387, 303-308.
23. Saurin, A.J., Borden, K.L., Boddy, M.N. and Freemont, P.S. (1996) Does this have a familiar RING? Trends Biochem. Sci., 21, 208-214.
24. Boddy, M.N., Freemont, P.S. and Borden, K.L. (1994) The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger. Trends Biochem. Sci., 19, 198-199.
25. Borden, K.L. and Freemont, P.S. (1996) The RING finger domain: a recent example of a sequence-structure family. Curr. Opin. Struct. Biol., 6, 395-401.
26. Lovering, R., Hanson, I.M., Borden, K.L., Martin, S., O'Reilly, N.J., Evan, G.I., Rahman, D., Pappin, D.J., Trowsdale, J. and Freemont, P.S. (1993) Identification and preliminary characterization of a protein motif related to the zinc finger. Proc. Natl Acad. Sci. USA, 90, 2112-2116.
27. Elenbaas, B., Dobbelstein, M., Roth, J., Shenk, T. and Levine, A.J. (1996) The MDM2 oncoprotein binds specifically to RNA through its RING finger domain. Mol. Med., 2, 439-451.
28. Clem, R.J. and Miller, L.K. (1994) Control of programmed cell death by the baculovirus genes p35 and iap. Mol. Cell. Biol., 14, 5212-5222.
29. Takahashi, R., Deveraux, Q., Tamm, I., Welsh, K., Assa Munt, N., Salvesen, G.S. and Reed, J.C. (1998) A single BIR domain of XIAP sufficient for inhibiting caspases. J. Biol. Chem., 273, 7787-7790.
30. Tyers, M. and Willems, A.R. (1999) One ring to rule a superfamily of E3 ubiquitin ligases. Science, 284, 601-604.
31. Kamura, T., Koepp, D.M., Conrad, M.N. et al. (1999) Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science, 284, 657-661.
32. Skowyra, D., Koepp, D.M., Kamura, T., Conrad, M.N., Conaway, R.C., Conaway, J.W., Elledge, S.J. and Harper, J.W. (1999) Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1. Science, 284, 662-665.
33. Ohta, J., Michel, J.J., Schottelius, A.J. and Xiong, Y. (1999) ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol. Cell, 3, 535-541.
34. Tan, P., Fuchs, S.Y., Chen, A., Wu, K., Gomez, C., Ronai, Z. and Pan, Z.-Q. (1999) Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of IκBα. Mol. Cell, 3, 527-533.
35. Beg, A.A. and Baltimore, D. (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death [see comments]. Science, 274, 782-784.
36. Mayo, M.W., Wang, C.Y., Cogswell, P.C., Rogers Graham, K.S., Lowe, S.W., Der, C.J. and Baldwin, A.S.Jr (1997) Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science, 278, 1812-1815.